According to Arrowhead Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is NZ-$5.92. In 2025 the company made an earnings per share (EPS) of NZ-$0.01777 an increase over its 2024 EPS that were of NZ-$8.88.